医保“绿色通道”打通，脑机接口加速从实验室狂飙至千亿级市场

Core Insights - The brain-computer interface (BCI) technology is experiencing a critical breakthrough in China, with the National Healthcare Security Administration (NHSA) opening a "green channel" for BCI and surgical robots to enter the medical insurance coding system, facilitating faster clinical application and commercialization [2][3] Policy Developments - The NHSA's announcement allows BCI products with medical device registration to expedite their coding process, while products without registration can submit technical materials for preliminary review, significantly reducing the time from approval to clinical application [3][4] - This policy aims to accelerate the application of cutting-edge medical technologies in clinical settings and supports genuine innovation in high-level medical products [3][4] Market Growth - The global BCI market is projected to grow from $1.2 billion in 2019 to $2 billion in 2023, with an expected compound annual growth rate (CAGR) of 17.5%, reaching $7.63 billion by 2029 [4][5] - Investment in the BCI sector has exceeded $10 billion globally, with the U.S. accounting for over 50% and China over $2 billion [4][5] Clinical Applications - The medical rehabilitation sector is the primary area for BCI technology application, with a significant increase in clinical trials from 11 in 2023 to 31 in 2024, addressing various conditions such as stroke rehabilitation and depression [5][6] - The demand for BCI technology is driven by the high incidence of stroke and the large population of individuals with disabilities in China [5][6] Future Prospects - BCI technology is expected to expand beyond medical applications into industrial manufacturing, education, elderly care, and emergency safety, indicating a broad potential for growth [6][7] - The integration of BCI technology with home medical devices could lead to comprehensive health management solutions, enhancing the competitive landscape for home healthcare [7]